Breaking News, Financial News

Financial Report: WuXi Pharma Tech 3Q

Lab Services up 26%, driven by China-based labs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi Pharma Tech

3Q Revenues: $125.8 million (+21%)

3Q Earnings: $213 million (+3%)

YTD Revenues: $374.3 million (+25%)

YTD Earnings: $62.8 million (+9%)

Comments: Laboratory Services were $98.9 million in the quarter, up 26%. China-based Lab Services increased 32% to $77.0 million. U.S.-based Lab Services were up 6% to $21.9 million. Manufacturing services were $26.9 million, up 7%.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters